Apple News In Conversation cover image

Why a 25-cent pill is being sold to cancer patients for nearly $1,000

Apple News In Conversation

00:00

Thalidomide: From Tragedy to Treatment

This chapter explores the controversial history of thalidomide, detailing its initial role in causing birth defects and its unexpected resurgence as a cancer treatment through its derivative, Revlimid. It also examines the ethical implications of drug pricing and the stark contrast between the drug's harmful effects and its potential to save lives in cancer therapy.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app